SolarEdge (Nasdaq: SEDG) grows 2025 revenue 31% and improves margins
SolarEdge Technologies reported strong recovery in 2025 with rapid growth but remained unprofitable. Fourth-quarter revenue reached $335.4 million, up 70% year over year and slightly below the prior quarter. GAAP gross margin improved to 22.2%, while non-GAAP gross margin rose to 23.3%.
For full-year 2025, revenue was $1.18 billion, up from $901.5 million in 2024. GAAP net loss narrowed to $405.4 million from $1.81 billion, and non-GAAP net loss fell to $140.3 million from $1.31 billion. Results included a one-time, non-cash $70.5 million finance expense tied to the liquidation of the Korean entity.
Cash generation turned around: operating cash flow was $104.3 million versus a $313.3 million deficit in 2024, and free cash flow improved to $76.9 million from a $421.5 million deficit. Cash and investments, net of debt, reached $244.2 million as of December 31, 2025.
Positive
- Major improvement in profitability metrics: GAAP gross margin rose to 16.6% in 2025 from negative 97.3% in 2024, and GAAP operating loss shrank to $301.7 million from $1.71 billion.
- Strong top-line growth: 2025 revenue increased to $1.18 billion from $901.5 million, while Q4 revenue grew 70% year over year to $335.4 million.
- Return to positive cash generation: Operating cash flow reached $104.3 million and free cash flow $76.9 million in 2025, versus large deficits in 2024.
Negative
- Continuing sizable net losses: Despite improvement, GAAP net loss in 2025 was still $405.4 million and non-GAAP net loss $140.3 million.
- Volatile financial items: 2025 results included a one-time, non-cash $70.5 million finance expense from exchange-rate effects tied to the Korean business liquidation, highlighting exposure to currency and restructuring impacts.
Insights
SolarEdge shows sharp 2025 recovery with positive cash flow but still sizable losses.
SolarEdge delivered a major turnaround in 2025. Revenue grew to $1.18 billion, up from $901.5 million, while GAAP gross margin swung from negative 97.3% in 2024 to positive 16.6%. Non-GAAP gross margin reached 16.7%, and operating losses shrank substantially.
Profitability remains a concern: GAAP net loss was still $405.4 million and non-GAAP net loss $140.3 million. Q4 results were affected by a one-time non-cash finance expense of $70.5 million from exchange-rate impacts related to liquidating the Korean business entity, temporarily depressing net income.
Cash generation improved markedly, with operating cash flow of $104.3 million and free cash flow of $76.9 million versus large deficits in 2024. Cash and investments net of debt reached $244.2 million as of December 31, 2025. Future filings will show whether margin gains and free cash flow are sustained as the company pursues growth initiatives described in its commentary.
8-K Event Classification
SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
(Address of Principal executive offices)
|
|
(Zip Code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
Nasdaq (Global Select Market)
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Exhibit No.
|
Description
|
|
Exhibit 99.1
|
Press release February 18, 2026
|
|
Exhibit 104
|
Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.
|
|
SOLAREDGE TECHNOLOGIES, INC.
|
|
|
Date: February 18, 2026
|
By: /s/Asaf Alperovitz
|
|
Name: Asaf Alperovitz
Title: Chief Financial
Officer
|

|
•
|
Revenues to be within the range of $290 million to $320 million; this range does not include significant one-time or pull forward of revenue.
|
|
•
|
Non-GAAP gross margin* expected to be
within the range of 20% to 24%
|
|
•
|
Non-GAAP operating expenses* to be
within the range of $88 million to $93 million.
|
A replay of the webcast will be available in the Investor Relations section of the Company’s web site approximately two hours after the conclusion of the call and will remain available for approximately 30 calendar days.
investors@solaredge.com
|
Three Months Ended
December 31, |
Year Ended
December 31, |
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Unaudited
|
||||||||||||||||
|
Revenues
|
$
|
335,358
|
$
|
196,217
|
$
|
1,184,444
|
$
|
901,456
|
||||||||
|
Cost of revenues
|
260,887
|
308,471
|
988,163
|
1,778,660
|
||||||||||||
|
Gross profit (loss)
|
74,471
|
(112,254
|
)
|
196,281
|
(877,204
|
)
|
||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development
|
51,726
|
62,238
|
221,255
|
277,237
|
||||||||||||
|
Sales and marketing
|
30,039
|
30,549
|
117,332
|
146,865
|
||||||||||||
|
General and administrative
|
24,489
|
36,370
|
101,035
|
147,455
|
||||||||||||
|
Other operating expenses, net
|
16,527
|
22,256
|
58,338
|
259,527
|
||||||||||||
|
Total operating expenses
|
122,781
|
151,413
|
497,960
|
831,084
|
||||||||||||
|
Operating loss
|
(48,310
|
)
|
(263,667
|
)
|
(301,679
|
)
|
(1,708,288
|
)
|
||||||||
|
Financial expense, net
|
(77,784
|
)
|
(12,199
|
)
|
(71,999
|
)
|
(14,570
|
)
|
||||||||
|
Other income (loss), net
|
(6,582
|
)
|
(76
|
)
|
(17,428
|
)
|
14,547
|
|||||||||
|
loss before income taxes
|
(132,676
|
)
|
(275,942
|
)
|
(391,106
|
)
|
(1,708,311
|
)
|
||||||||
|
Tax benefits (Income taxes)
|
564
|
(11,041
|
)
|
(13,382
|
)
|
(96,150
|
)
|
|||||||||
|
Net loss from equity method investments
|
(9
|
)
|
(456
|
)
|
(960
|
)
|
(1,896
|
)
|
||||||||
|
Net loss
|
$
|
(132,121
|
)
|
$
|
(287,439
|
)
|
$
|
(405,448
|
)
|
$
|
(1,806,357
|
)
|
||||
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
455,075
|
$
|
274,611
|
||||
|
Restricted cash
|
84,771
|
135,328
|
||||||
|
Marketable securities
|
38,097
|
311,279
|
||||||
|
Trade receivables, net of allowances of $17,224 and $43,038, respectively
|
267,441
|
160,423
|
||||||
|
Inventories, net
|
552,632
|
645,897
|
||||||
|
Prepaid expenses and other current assets
|
341,831
|
523,027
|
||||||
|
Total current assets
|
1,739,847
|
2,050,565
|
||||||
|
LONG-TERM ASSETS:
|
||||||||
|
Marketable securities
|
—
|
42,597
|
||||||
|
Property, plant and equipment, net
|
269,351
|
343,438
|
||||||
|
Operating lease right-of-use assets, net
|
48,178
|
41,393
|
||||||
|
Intangible assets, net
|
7,129
|
9,666
|
||||||
|
Goodwill
|
50,123
|
48,380
|
||||||
|
Loan receivables, net
|
—
|
45,678
|
||||||
|
Other long-term assets
|
67,566
|
64,736
|
||||||
|
Total long-term assets
|
442,347
|
595,888
|
||||||
|
Total assets
|
2,182,194
|
2,646,453
|
||||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables
|
271,983
|
107,543
|
||||||
|
Employees and payroll accruals
|
73,992
|
76,292
|
||||||
|
Warranty obligations
|
89,330
|
140,249
|
||||||
|
Deferred revenues and customers advances
|
70,371
|
140,870
|
||||||
|
Accrued expenses and other current liabilities
|
297,819
|
246,078
|
||||||
|
Convertible senior notes, net
|
—
|
346,305
|
||||||
|
Total current liabilities
|
803,495
|
1,057,337
|
||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Convertible senior notes, net
|
331,561
|
330,006
|
||||||
|
Warranty obligations
|
268,559
|
292,116
|
||||||
|
Deferred revenues and customers advances
|
293,328
|
231,049
|
||||||
|
Finance lease liabilities
|
18,558
|
39,159
|
||||||
|
Operating lease liabilities
|
36,648
|
30,018
|
||||||
|
Other long-term liabilities
|
2,581
|
8,426
|
||||||
|
Total long-term liabilities
|
951,235
|
930,774
|
||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
|
STOCKHOLDERS’ EQUITY:
|
||||||||
|
Common stock of $0.0001 par value - Authorized: 125,000,000 shares; issued: 60,360,154 shares as of
December 31, 2025 and 58,780,490 shares as of December 31, 2024; outstanding: 60,360,154 shares as of December 31, 2025 and 58,027,126 shares as of December 31, 2024.
|
6
|
6
|
||||||
|
Additional paid-in capital
|
1,872,760
|
1,813,198
|
||||||
|
Treasury stock, at cost; 0 and 753,364 stocks held as of December 31, 2025 and December 31, 2024,
respectively
|
—
|
(50,194
|
)
|
|||||
|
Accumulated other comprehensive loss
|
(11,663
|
)
|
(76,477
|
)
|
||||
|
Accumulated deficit
|
(1,433,639
|
)
|
(1,028,191
|
)
|
||||
|
Total stockholders’ equity
|
427,464
|
658,342
|
||||||
|
Total liabilities and stockholders’
equity
|
$
|
2,182,194
|
$
|
2,646,453
|
||||
|
Year ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(405,448
|
)
|
$
|
(1,806,357
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation and amortization
|
30,511
|
59,865
|
||||||
|
Provision to write down inventories to net realizable value
|
17,827
|
738,757
|
||||||
|
Impairment of asset held-for-sale
|
42,746
|
—
|
||||||
|
Loss on impairment and disposal of property, plant and equipment
|
5,799
|
224,772
|
||||||
|
Stock-based compensation expenses
|
92,545
|
137,251
|
||||||
|
Loss from business disposition
|
17,875
|
—
|
||||||
|
Impairment of goodwill and intangible assets
|
—
|
24,674
|
||||||
|
Impairment of privately-held companies
|
21,587
|
5,000
|
||||||
|
Deferred income taxes, net
|
(761
|
)
|
79,209
|
|||||
|
Gain from repurchasing of convertible notes
|
—
|
(15,456
|
)
|
|||||
|
Loss from exchange rate fluctuations
|
2,594
|
11,918
|
||||||
|
Loss (gain) from sale of property, plant and equipment
|
(3,058
|
)
|
1,522
|
|||||
|
Cumulative translation adjustment, including intra-entity transactions that are of a long-term investment
reclassified from other comprehensive loss
|
58,916
|
—
|
||||||
|
Other items
|
866
|
1,508
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Trade receivables, net
|
(105,923
|
)
|
451,707
|
|||||
|
Inventories, net
|
97,230
|
67,799
|
||||||
|
Prepaid expenses and other assets
|
107,055
|
7,369
|
||||||
|
Operating lease right-of-use assets, net
|
11,342
|
15,805
|
||||||
|
Trade payables
|
164,808
|
(405,990
|
)
|
|||||
|
Warranty obligations
|
(72,101
|
)
|
(85,541
|
)
|
||||
|
Deferred revenues and customers advances
|
(5,781
|
)
|
119,519
|
|||||
|
Operating lease liabilities
|
(13,360
|
)
|
(15,829
|
)
|
||||
|
Accrued expenses and other liabilities
|
38,992
|
69,179
|
||||||
|
Net cash provided by (used in) operating activities
|
104,261
|
(313,319
|
)
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Investment in available-for-sale marketable securities
|
(471,158
|
)
|
(253,431
|
)
|
||||
|
Proceeds from maturities of available-for-sale marketable securities
|
713,413
|
719,454
|
||||||
|
Proceeds from sales of available-for-sale marketable securities
|
76,288
|
114,564
|
||||||
|
Purchase of property, plant and equipment
|
(23,467
|
)
|
(108,163
|
)
|
||||
|
Proceeds from sale of investment in privately-held company
|
4,000
|
—
|
||||||
|
Business dispositions, net of cash sold
|
(7,322
|
)
|
—
|
|||||
|
Business combinations, net of cash acquired
|
—
|
(10,417
|
)
|
|||||
|
Proceeds from sale of property, plant and equipment
|
37,642
|
1,876
|
||||||
|
Advance related to held-for-sale asset
|
7,000
|
—
|
||||||
|
Purchase of intangible assets
|
—
|
(10,000
|
)
|
|||||
|
Disbursements for loans receivables
|
—
|
(37,500
|
)
|
|||||
|
Investment in privately-held companies
|
(300
|
)
|
(25,664
|
)
|
||||
|
Proceeds from loans receivables
|
53,585
|
32,150
|
||||||
|
Repayment related to governmental grant
|
(6,643
|
)
|
—
|
|||||
|
Other investing activities
|
(3,156
|
)
|
(6,583
|
)
|
||||
|
Net cash provided by investing activities
|
379,882
|
416,286
|
||||||
|
Cash flows from financing activities:
|
||||||||
|
Repurchase of common stock
|
—
|
(50,194
|
)
|
|||||
|
Repurchase of convertible debt
|
(5,093
|
)
|
(267,900
|
)
|
||||
|
Proceeds from issuance of Notes 2029, net of issuance costs
|
—
|
329,214
|
||||||
|
Capped call transactions related to Notes 2029
|
—
|
(28,342
|
)
|
|||||
|
Repayment of convertible notes at maturity
|
(342,250
|
)
|
—
|
|||||
|
Tax withholding in connection with stock-based awards, net
|
2,665
|
(281
|
)
|
|||||
|
Other financing activities
|
(4,212
|
)
|
(2,626
|
)
|
||||
|
Net cash used in financing activities
|
(348,890
|
)
|
(20,129
|
)
|
||||
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
3,344
|
(11,367
|
)
|
|||||
|
Increase in cash, cash equivalents and restricted cash including cash classified within current held-for-sale assets
|
138,597
|
71,471
|
||||||
|
Less: change in cash classified within current held-for-sale assets
|
(8,690
|
)
|
—
|
|||||
|
Increase in cash, cash equivalents, and restricted cash
|
129,907
|
71,471
|
||||||
|
Cash, cash equivalents and restricted cash, beginning of period
|
409,939
|
338,468
|
||||||
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
539,846
|
$
|
409,939
|
||||
|
Three months ended
|
Year ended
|
|||||||||||||||||||||||||||||||
|
December 31, 2025
|
September 30, 2025
|
June 30, 2025
|
March 31, 2025
|
December 31, 2024
|
December 31, 2025
|
December 31, 2024
|
December 31, 2023
|
|||||||||||||||||||||||||
|
Gross profit (loss) (GAAP)
|
$
|
74,471
|
$
|
72,143
|
$
|
32,131
|
$
|
17,536
|
$
|
(112,254
|
)
|
$
|
196,281
|
$
|
(877,204
|
)
|
$
|
703,823
|
||||||||||||||
|
Revenues from finance component
|
(456
|
)
|
(351
|
)
|
(304
|
)
|
(264
|
)
|
(254
|
)
|
(1,375
|
)
|
(984
|
)
|
(834
|
)
|
||||||||||||||||
|
Discontinued operation revenues
|
(1,107
|
)
|
(85
|
)
|
(8,132
|
)
|
(7,098
|
)
|
—
|
(16,422
|
)
|
—
|
—
|
|||||||||||||||||||
|
Discontinued operation cost of revenues
|
(331
|
)
|
(13,101
|
)
|
7,834
|
792
|
26,118
|
(4,806
|
)
|
24,921
|
36,648
|
|||||||||||||||||||||
|
Stock-based compensation
|
3,687
|
3,959
|
4,004
|
4,372
|
3,727
|
16,022
|
21,952
|
23,200
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
613
|
825
|
882
|
381
|
1,095
|
2,701
|
3,138
|
1,100
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired asset
|
495
|
501
|
483
|
491
|
484
|
1,970
|
5,412
|
6,038
|
||||||||||||||||||||||||
|
Restructuring charges
|
344
|
31
|
10
|
430
|
3,770
|
815
|
15,327
|
23,154
|
||||||||||||||||||||||||
|
Gross profit (loss) (Non-GAAP)
|
$
|
77,716
|
$
|
63,922
|
$
|
36,908
|
$
|
16,640
|
$
|
(77,314
|
)
|
$
|
195,186
|
$
|
(807,438
|
)
|
$
|
793,129
|
||||||||||||||
|
Gross margin (loss) (GAAP)
|
22.2
|
%
|
21.2
|
%
|
11.1
|
%
|
8.0
|
%
|
(57.2
|
)%
|
16.6
|
%
|
(97.3
|
)%
|
23.6
|
%
|
||||||||||||||||
|
Revenues from finance component
|
0.0
|
0.0
|
0.0
|
0.0
|
(0.1
|
)
|
(0.1
|
)
|
(0.1
|
)
|
0.0
|
|||||||||||||||||||||
|
Discontinued operation revenues
|
0.0
|
0.0
|
(2.8
|
)
|
(3.2
|
)
|
—
|
(1.4
|
)
|
—
|
—
|
|||||||||||||||||||||
|
Discontinued operation cost of revenues
|
0.0
|
(3.9
|
)
|
3.0
|
0.4
|
13.3
|
(0.4
|
)
|
2.8
|
1.2
|
||||||||||||||||||||||
|
Stock-based compensation
|
1.1
|
1.2
|
1.4
|
2.0
|
1.9
|
1.4
|
2.4
|
0.9
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
0.0
|
0.2
|
0.3
|
0.2
|
0.6
|
0.2
|
0.3
|
0.0
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired asset
|
0.0
|
0.1
|
0.2
|
0.2
|
0.2
|
0.3
|
0.6
|
0.2
|
||||||||||||||||||||||||
|
Restructuring charges
|
0.0
|
0.0
|
0.0
|
0.2
|
1.9
|
0.1
|
1.7
|
0.8
|
||||||||||||||||||||||||
|
Gross margin (loss) (Non-GAAP)
|
23.3
|
%
|
18.8
|
%
|
13.2
|
%
|
7.8
|
%
|
(39.4
|
)%
|
16.7
|
%
|
(89.6
|
)%
|
26.7
|
%
|
||||||||||||||||
|
Operating expenses (GAAP)
|
$
|
122,781
|
$
|
107,293
|
$
|
147,624
|
$
|
120,262
|
$
|
151,413
|
$
|
497,960
|
$
|
831,084
|
$
|
663,618
|
||||||||||||||||
|
Stock-based compensation - R&D
|
(8,442
|
)
|
(10,681
|
)
|
(9,856
|
)
|
(15,911
|
)
|
(10,653
|
)
|
(44,890
|
)
|
(62,546
|
)
|
(66,944
|
)
|
||||||||||||||||
|
Stock-based compensation - S&M
|
(4,298
|
)
|
(4,348
|
)
|
(4,342
|
)
|
(4,742
|
)
|
(4,452
|
)
|
(17,730
|
)
|
(27,328
|
)
|
(30,987
|
)
|
||||||||||||||||
|
Stock-based compensation - G&A
|
(3,546
|
)
|
(2,897
|
)
|
(1,059
|
)
|
(6,401
|
)
|
(5,600
|
)
|
(13,903
|
)
|
(25,425
|
)
|
(28,814
|
)
|
||||||||||||||||
|
Amortization and depreciation of acquired assets - R&D
|
—
|
—
|
—
|
—
|
(189
|
)
|
—
|
(1,000
|
)
|
(989
|
)
|
|||||||||||||||||||||
|
Amortization and depreciation of acquired assets - S&M
|
(116
|
)
|
(116
|
)
|
(116
|
)
|
(424
|
)
|
(442
|
)
|
(772
|
)
|
(1,599
|
)
|
(927
|
)
|
||||||||||||||||
|
Amortization and depreciation of acquired assets - G&A
|
—
|
—
|
—
|
—
|
—
|
—
|
(6
|
)
|
(15
|
)
|
||||||||||||||||||||||
|
Discontinued operation
|
(6,989
|
)
|
(316
|
)
|
(27,069
|
)
|
(1,522
|
)
|
(3,350
|
)
|
(35,896
|
)
|
(3,293
|
)
|
(388
|
)
|
||||||||||||||||
|
Restructuring charges
|
(423
|
)
|
(426
|
)
|
(867
|
)
|
(2,613
|
)
|
—
|
(4,329
|
)
|
(5,607
|
)
|
—
|
||||||||||||||||||
|
Assets impairment and disposal by abandonment
|
(3,135
|
)
|
(672
|
)
|
(1,967
|
)
|
(224
|
)
|
(17,989
|
)
|
(5,998
|
)
|
(251,823
|
)
|
(30,790
|
)
|
||||||||||||||||
|
Gain (loss) from assets sales
|
(7,117
|
)
|
(158
|
)
|
(17,108
|
)
|
662
|
(1,910
|
)
|
(23,721
|
)
|
(5,746
|
)
|
1,262
|
||||||||||||||||||
|
Certain litigation and other contingencies
|
—
|
—
|
—
|
—
|
—
|
—
|
399
|
(1,786
|
)
|
|||||||||||||||||||||||
|
Acquisition costs
|
—
|
—
|
—
|
—
|
—
|
—
|
(9
|
)
|
(135
|
)
|
||||||||||||||||||||||
|
Operating expenses (Non-GAAP)
|
$
|
88,715
|
$
|
87,679
|
$
|
85,240
|
$
|
89,087
|
$
|
106,828
|
$
|
350,721
|
$
|
447,101
|
$
|
503,105
|
||||||||||||||||
|
Three months ended
|
Year ended
|
|||||||||||||||||||||||||||||||
|
December
31, 2025
|
September
30, 2025
|
June
30, 2025
|
March
31, 2025
|
December
31, 2024
|
December
31, 2025
|
December
31, 2024
|
December
31, 2023
|
|||||||||||||||||||||||||
|
Operating income (loss) (GAAP)
|
$
|
(48,310
|
)
|
$
|
(35,150
|
)
|
$
|
(115,493
|
)
|
$
|
(102,726
|
)
|
$
|
(263,667
|
)
|
$
|
(301,679
|
)
|
$
|
(1,708,288
|
)
|
$
|
40,205
|
|||||||||
|
Revenues from finance component
|
(456
|
)
|
(351
|
)
|
(304
|
)
|
(264
|
)
|
(254
|
)
|
(1,375
|
)
|
(984
|
)
|
(834
|
)
|
||||||||||||||||
|
Discontinued operation
|
5,551
|
(12,870
|
)
|
26,771
|
(4,784
|
)
|
29,468
|
14,668
|
28,214
|
37,036
|
||||||||||||||||||||||
|
Stock-based compensation
|
19,973
|
21,885
|
19,261
|
31,426
|
24,432
|
92,545
|
137,251
|
149,945
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
613
|
825
|
882
|
381
|
1,095
|
2,701
|
3,138
|
1,100
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired assets
|
611
|
617
|
599
|
915
|
1,115
|
2,742
|
8,017
|
7,969
|
||||||||||||||||||||||||
|
Restructuring charges
|
767
|
457
|
877
|
3,043
|
3,770
|
5,144
|
20,934
|
23,154
|
||||||||||||||||||||||||
|
Assets impairment and disposal by abandonment
|
3,135
|
672
|
1,967
|
224
|
17,989
|
5,998
|
251,823
|
30,790
|
||||||||||||||||||||||||
|
Loss (gain) from assets sales
|
7,117
|
158
|
17,108
|
(662
|
)
|
1,910
|
23,721
|
5,746
|
(1,262
|
)
|
||||||||||||||||||||||
|
Certain litigation and other contingencies
|
—
|
—
|
—
|
—
|
—
|
—
|
(399
|
)
|
1,786
|
|||||||||||||||||||||||
|
Acquisition costs
|
—
|
—
|
—
|
—
|
—
|
—
|
9
|
135
|
||||||||||||||||||||||||
|
Operating income (loss) (Non-GAAP)
|
$
|
(10,999
|
)
|
$
|
(23,757
|
)
|
$
|
(48,332
|
)
|
$
|
(72,447
|
)
|
$
|
(184,142
|
)
|
$
|
(155,535
|
)
|
$
|
(1,254,539
|
)
|
$
|
290,024
|
|||||||||
|
Financial income (expense), net (GAAP)
|
$
|
(77,784
|
)
|
$
|
3,040
|
$
|
(7,323
|
)
|
$
|
10,068
|
$
|
(12,199
|
)
|
$
|
(71,999
|
)
|
$
|
(14,570
|
)
|
$
|
41,212
|
|||||||||||
|
Non cash interest expense
|
4,420
|
4,462
|
4,326
|
4,051
|
3,920
|
17,259
|
14,877
|
12,703
|
||||||||||||||||||||||||
|
Currency fluctuation related to lease standard
|
3,360
|
1,552
|
7,151
|
(1,633
|
)
|
1,089
|
10,430
|
(744
|
)
|
(3,055
|
)
|
|||||||||||||||||||||
|
Discontinued operation
|
1,402
|
(958
|
)
|
2,265
|
(276
|
)
|
—
|
2,433
|
—
|
—
|
||||||||||||||||||||||
|
CTA reclassification upon liquidation of a foreign subsidiary
|
59,520
|
—
|
—
|
—
|
—
|
59,520
|
—
|
—
|
||||||||||||||||||||||||
|
One‑time foreign exchange impact from VAT settlement agreement
|
10,963
|
—
|
—
|
—
|
—
|
10,963
|
—
|
—
|
||||||||||||||||||||||||
|
Financial income (expense), net (Non-GAAP)
|
$
|
1,881
|
$
|
8,096
|
$
|
6,419
|
$
|
12,210
|
$
|
(7,190
|
)
|
$
|
28,606
|
$
|
(437
|
)
|
$
|
50,860
|
||||||||||||||
|
Other income (loss) (GAAP)
|
$
|
(6,582
|
)
|
$
|
(15,011
|
)
|
$
|
4,017
|
$
|
148
|
$
|
(76
|
)
|
$
|
(17,428
|
)
|
$
|
14,547
|
$
|
(318
|
)
|
|||||||||||
|
Loss (gain) from sale of equity and debt investments
|
—
|
—
|
—
|
(2
|
)
|
76
|
(2
|
)
|
(2,966
|
)
|
193
|
|||||||||||||||||||||
|
Loss (gain) from business combination
|
—
|
—
|
—
|
—
|
—
|
—
|
(1,125
|
)
|
—
|
|||||||||||||||||||||||
|
Gain from the repurchase of convertible notes
|
—
|
—
|
—
|
(146
|
)
|
—
|
(146
|
)
|
(15,456
|
)
|
—
|
|||||||||||||||||||||
|
Gain From sale of private held companies
|
155
|
—
|
(4,017
|
)
|
—
|
—
|
(3,862
|
)
|
—
|
—
|
||||||||||||||||||||||
|
Loss from impairment of private held companies
|
6,427
|
15,011
|
—
|
—
|
—
|
21,438
|
5,000
|
—
|
||||||||||||||||||||||||
|
Other income (loss) (Non-GAAP)
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
(125
|
)
|
|||||||||||||||
|
Income tax benefit (expense) (GAAP)
|
$
|
564
|
$
|
(2,563
|
)
|
$
|
(5,657
|
)
|
$
|
(5,726
|
)
|
$
|
(11,041
|
)
|
$
|
(13,382
|
)
|
$
|
(96,150
|
)
|
$
|
(46,420
|
)
|
|||||||||
|
Income tax adjustment
|
389
|
(124
|
)
|
(100
|
)
|
(155
|
)
|
(176
|
)
|
10
|
39,007
|
(45,896
|
)
|
|||||||||||||||||||
|
Income tax benefit (expense) (Non-GAAP)
|
$
|
953
|
$
|
(2,687
|
)
|
$
|
(5,757
|
)
|
$
|
(5,881
|
)
|
$
|
(11,217
|
)
|
$
|
(13,372
|
)
|
$
|
(57,143
|
)
|
$
|
(92,316
|
)
|
|||||||||
|
Equity method investments income (loss) (GAAP)
|
$
|
(9
|
)
|
$
|
(376
|
)
|
$
|
(288
|
)
|
$
|
(287
|
)
|
$
|
(456
|
)
|
$
|
(960
|
)
|
$
|
(1,896
|
)
|
$
|
(350
|
)
|
||||||||
|
Loss from equity method investments
|
9
|
376
|
288
|
287
|
456
|
960
|
1,896
|
350
|
||||||||||||||||||||||||
|
Equity method investments income (loss) (Non-GAAP)
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||||||||||||
|
Three months ended
|
Year ended
|
|||||||||||||||||||||||||||||||
|
December
31, 2025
|
September
30, 2025
|
June
30, 2025
|
March
31, 2025 |
December
31, 2024
|
December
31, 2025
|
December
31, 2024
|
December
31, 2023 |
|||||||||||||||||||||||||
|
Net income (loss) (GAAP)
|
$
|
(132,121
|
)
|
$
|
(50,060
|
)
|
$
|
(124,744
|
)
|
$
|
(98,523
|
)
|
$
|
(287,439
|
)
|
$
|
(405,448
|
)
|
$
|
(1,806,357
|
)
|
$
|
34,329
|
|||||||||
|
Revenues from finance component
|
(456
|
)
|
(351
|
)
|
(304
|
)
|
(264
|
)
|
(254
|
)
|
(1,375
|
)
|
(984
|
)
|
(834
|
)
|
||||||||||||||||
|
Discontinued operation
|
6,953
|
(13,828
|
)
|
29,036
|
(5,060
|
)
|
29,468
|
17,101
|
28,214
|
37,036
|
||||||||||||||||||||||
|
Stock-based compensation
|
19,973
|
21,885
|
19,261
|
31,426
|
24,432
|
92,545
|
137,251
|
149,945
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
613
|
825
|
882
|
381
|
1,095
|
2,701
|
3,138
|
1,100
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired assets
|
611
|
617
|
599
|
915
|
1,115
|
2,742
|
8,017
|
7,969
|
||||||||||||||||||||||||
|
Restructuring charges
|
767
|
457
|
877
|
3,043
|
3,770
|
5,144
|
20,934
|
23,154
|
||||||||||||||||||||||||
|
Assets impairment and disposal by abandonment
|
3,135
|
672
|
1,967
|
224
|
17,989
|
5,998
|
251,823
|
30,790
|
||||||||||||||||||||||||
|
Loss (gain) from assets sales
|
7,117
|
158
|
17,108
|
(662
|
)
|
1,910
|
23,721
|
5,746
|
(1,262
|
)
|
||||||||||||||||||||||
|
Certain litigation and other contingencies
|
—
|
—
|
—
|
—
|
—
|
—
|
(399
|
)
|
1,786
|
|||||||||||||||||||||||
|
Acquisition costs
|
—
|
—
|
—
|
—
|
—
|
—
|
9
|
135
|
||||||||||||||||||||||||
|
Non cash interest expense
|
4,420
|
4,462
|
4,326
|
4,051
|
3,920
|
17,259
|
14,877
|
12,703
|
||||||||||||||||||||||||
|
CTA reclassification upon liquidation of a foreign subsidiary
|
59,520
|
—
|
—
|
—
|
—
|
59,520
|
—
|
—
|
||||||||||||||||||||||||
|
One‑time foreign exchange impact from VAT settlement agreement
|
10,963
|
—
|
—
|
—
|
—
|
10,963
|
—
|
—
|
||||||||||||||||||||||||
|
Currency fluctuation related to lease standard
|
3,360
|
1,552
|
7,151
|
(1,633
|
)
|
1,089
|
10,430
|
(744
|
)
|
(3,055
|
)
|
|||||||||||||||||||||
|
Loss (gain) from sale of equity and debt investments
|
—
|
—
|
—
|
(2
|
)
|
76
|
(2
|
)
|
(2,966
|
)
|
193
|
|||||||||||||||||||||
|
Loss (gain) from business combination
|
—
|
—
|
—
|
—
|
—
|
—
|
(1,125
|
)
|
—
|
|||||||||||||||||||||||
|
Gain from the repurchase of convertible notes
|
—
|
—
|
—
|
(146
|
)
|
—
|
(146
|
)
|
(15,456
|
)
|
—
|
|||||||||||||||||||||
|
Gain From sale of private held companies
|
155
|
—
|
(4,017
|
)
|
—
|
—
|
(3,862
|
)
|
—
|
—
|
||||||||||||||||||||||
|
Loss from impairment of private held companies
|
6,427
|
15,011
|
—
|
—
|
—
|
21,438
|
5,000
|
—
|
||||||||||||||||||||||||
|
Income tax adjustment
|
389
|
(124
|
)
|
(100
|
)
|
(155
|
)
|
(176
|
)
|
10
|
39,007
|
(45,896
|
)
|
|||||||||||||||||||
|
equity method adjustments
|
9
|
376
|
288
|
287
|
456
|
960
|
1,896
|
350
|
||||||||||||||||||||||||
|
Net income (loss) (Non-GAAP)
|
$
|
(8,165
|
)
|
$
|
(18,348
|
)
|
$
|
(47,670
|
)
|
$
|
(66,118
|
)
|
$
|
(202,549
|
)
|
$
|
(140,301
|
)
|
$
|
(1,312,119
|
)
|
$
|
248,443
|
|||||||||
|
Three months ended
|
Year ended
|
|||||||||||||||||||||||||||||||
|
December
31, 2025
|
September
30, 2025
|
June
30, 2025 |
March
31, 2025
|
December
31, 2024
|
December
31, 2025
|
December
31, 2024
|
December
31, 2023
|
|||||||||||||||||||||||||
|
Net basic earnings (loss) per share (GAAP)
|
$
|
(2.21
|
)
|
$
|
(0.84
|
)
|
$
|
(2.13
|
)
|
$
|
(1.70
|
)
|
$
|
(5.00
|
)
|
$
|
(6.88
|
)
|
$
|
(31.64
|
)
|
$
|
0.61
|
|||||||||
|
Revenues from finance component
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
0.00
|
(0.01
|
)
|
(0.02
|
)
|
(0.02
|
)
|
(0.02
|
)
|
|||||||||||||||||
|
Discontinued operation
|
0.12
|
(0.23
|
)
|
0.50
|
(0.09
|
)
|
0.52
|
0.29
|
0.49
|
0.66
|
||||||||||||||||||||||
|
Stock-based compensation
|
0.33
|
0.37
|
0.33
|
0.54
|
0.42
|
1.57
|
2.41
|
2.65
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
0.01
|
0.01
|
0.01
|
0.01
|
0.02
|
0.05
|
0.05
|
0.02
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired assets
|
0.01
|
0.01
|
0.01
|
0.02
|
0.02
|
0.04
|
0.14
|
0.14
|
||||||||||||||||||||||||
|
Restructuring charges
|
0.02
|
0.01
|
0.02
|
0.05
|
0.07
|
0.09
|
0.37
|
0.41
|
||||||||||||||||||||||||
|
Assets impairment and disposal by abandonment
|
0.05
|
0.01
|
0.03
|
0.00
|
0.31
|
0.10
|
4.41
|
0.54
|
||||||||||||||||||||||||
|
Loss (gain) from assets sales
|
0.12
|
0.00
|
0.30
|
(0.01
|
)
|
0.03
|
0.40
|
0.10
|
(0.02
|
)
|
||||||||||||||||||||||
|
Certain litigation and other contingencies
|
—
|
—
|
—
|
—
|
—
|
—
|
(0.01
|
)
|
0.03
|
|||||||||||||||||||||||
|
Acquisition costs
|
—
|
—
|
—
|
—
|
—
|
—
|
0.00
|
0.00
|
||||||||||||||||||||||||
|
Non cash interest expense
|
0.07
|
0.08
|
0.07
|
0.07
|
0.07
|
0.30
|
0.26
|
0.23
|
||||||||||||||||||||||||
|
CTA reclassification upon liquidation of a foreign subsidiary
|
1.00
|
—
|
—
|
—
|
—
|
1.01
|
—
|
—
|
||||||||||||||||||||||||
|
One‑time foreign exchange impact from VAT settlement
|
0.18
|
—
|
—
|
—
|
—
|
0.18
|
—
|
—
|
||||||||||||||||||||||||
|
Currency fluctuation related to lease standard
|
0.06
|
0.02
|
0.12
|
(0.03
|
)
|
0.02
|
0.18
|
(0.01
|
)
|
(0.06
|
)
|
|||||||||||||||||||||
|
Loss (gain) from sale of equity and debt investments
|
—
|
—
|
—
|
0.00
|
0.00
|
0.00
|
(0.05
|
)
|
0.01
|
|||||||||||||||||||||||
|
Loss (gain) from business combination
|
—
|
—
|
—
|
—
|
—
|
—
|
(0.02
|
)
|
—
|
|||||||||||||||||||||||
|
Gain from the repurchase of convertible notes
|
—
|
—
|
—
|
0.00
|
—
|
0.00
|
(0.27
|
)
|
—
|
|||||||||||||||||||||||
|
Gain From sale of private held companies
|
0.00
|
—
|
(0.06
|
)
|
—
|
—
|
(0.07
|
)
|
—
|
—
|
||||||||||||||||||||||
|
Loss from impairment of private held companies
|
0.11
|
0.26
|
—
|
—
|
—
|
0.36
|
0.09
|
—
|
||||||||||||||||||||||||
|
Income tax adjustment
|
0.00
|
(0.01
|
)
|
0.00
|
0.00
|
0.00
|
0.00
|
0.68
|
(0.81
|
)
|
||||||||||||||||||||||
|
equity method adjustments
|
0.00
|
0.01
|
0.00
|
0.00
|
0.01
|
0.02
|
0.03
|
0.00
|
||||||||||||||||||||||||
|
Net basic earnings (loss) per share (Non-GAAP)
|
$
|
(0.14
|
)
|
$
|
(0.31
|
)
|
$
|
(0.81
|
)
|
$
|
(1.14
|
)
|
$
|
(3.52
|
)
|
$
|
(2.38
|
)
|
$
|
(22.99
|
)
|
$
|
4.39
|
|||||||||
|
Three months ended
|
Year ended
|
|||||||||||||||||||||||||||||||
|
December
31, 2025
|
September
30, 2025
|
June
30, 2025
|
March
31, 2025
|
December
31, 2024
|
December
31, 2025
|
December
31, 2024 |
December
31, 2023
|
|||||||||||||||||||||||||
|
Net diluted earnings (loss) per share (GAAP)
|
$
|
(2.21
|
)
|
$
|
(0.84
|
)
|
$
|
(2.13
|
)
|
$
|
(1.70
|
)
|
$
|
(5.00
|
)
|
$
|
(6.88
|
)
|
$
|
(31.64
|
)
|
$
|
0.60
|
|||||||||
|
Revenues from finance component
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
0.00
|
(0.01
|
)
|
(0.02
|
)
|
(0.02
|
)
|
(0.01
|
)
|
|||||||||||||||||
|
Discontinued operation
|
0.12
|
(0.23
|
)
|
0.50
|
(0.09
|
)
|
0.52
|
0.29
|
0.49
|
0.64
|
||||||||||||||||||||||
|
Stock-based compensation
|
0.33
|
0.37
|
0.33
|
0.54
|
0.42
|
1.57
|
2.41
|
2.57
|
||||||||||||||||||||||||
|
Amortization of stock-based compensation capitalized in inventories
|
0.01
|
0.01
|
0.01
|
0.01
|
0.02
|
0.05
|
0.05
|
0.02
|
||||||||||||||||||||||||
|
Amortization and depreciation of acquired assets
|
0.01
|
0.01
|
0.01
|
0.02
|
0.02
|
0.04
|
0.14
|
0.14
|
||||||||||||||||||||||||
|
Restructuring charges
|
0.02
|
0.01
|
0.02
|
0.05
|
0.07
|
0.09
|
0.37
|
0.40
|
||||||||||||||||||||||||
|
Assets impairment and disposal by abandonment
|
0.05
|
0.01
|
0.03
|
0.00
|
0.31
|
0.10
|
4.41
|
0.53
|
||||||||||||||||||||||||
|
Loss (gain) from assets sales
|
0.12
|
0.00
|
0.30
|
(0.01
|
)
|
0.03
|
0.40
|
0.10
|
(0.02
|
)
|
||||||||||||||||||||||
|
Certain litigation and other contingencies
|
—
|
—
|
—
|
—
|
—
|
—
|
(0.01
|
)
|
0.03
|
|||||||||||||||||||||||
|
Acquisition costs
|
—
|
—
|
—
|
—
|
—
|
—
|
0.00
|
0.00
|
||||||||||||||||||||||||
|
Non cash interest expense
|
0.07
|
0.08
|
0.07
|
0.07
|
0.07
|
0.30
|
0.26
|
0.03
|
||||||||||||||||||||||||
|
CTA reclassification upon liquidation of a foreign subsidiary
|
1.00
|
—
|
—
|
—
|
—
|
1.01
|
—
|
—
|
||||||||||||||||||||||||
|
One‑time foreign exchange impact from VAT settlement agreement
|
0.18
|
—
|
—
|
—
|
—
|
0.18
|
—
|
—
|
||||||||||||||||||||||||
|
Currency fluctuation related to lease standard
|
0.06
|
0.02
|
0.12
|
(0.03
|
)
|
0.02
|
0.18
|
(0.01
|
)
|
(0.05
|
)
|
|||||||||||||||||||||
|
Loss (gain) from sale of equity and debt investments
|
—
|
—
|
—
|
0.00
|
0.00
|
0.00
|
(0.05
|
)
|
0.00
|
|||||||||||||||||||||||
|
Loss (gain) from business combination
|
—
|
—
|
—
|
—
|
—
|
—
|
(0.02
|
)
|
—
|
|||||||||||||||||||||||
|
Gain from the repurchase of convertible notes
|
—
|
—
|
—
|
0.00
|
—
|
0.00
|
(0.27
|
)
|
—
|
|||||||||||||||||||||||
|
Gain From sale of private held companies
|
0.00
|
—
|
(0.06
|
)
|
—
|
—
|
(0.07
|
)
|
—
|
—
|
||||||||||||||||||||||
|
Loss from impairment of private held companies
|
0.11
|
0.26
|
0.00
|
—
|
—
|
0.36
|
0.09
|
—
|
||||||||||||||||||||||||
|
Income tax adjustment
|
0.00
|
(0.01
|
)
|
0.00
|
0.00
|
0.00
|
0.00
|
0.68
|
(0.76
|
)
|
||||||||||||||||||||||
|
equity method adjustments
|
0.00
|
0.01
|
0.00
|
0.00
|
0.01
|
0.02
|
0.03
|
0.00
|
||||||||||||||||||||||||
|
Net diluted earnings (loss) per share (Non-GAAP)
|
$
|
(0.14
|
)
|
$
|
(0.31
|
)
|
$
|
(0.81
|
)
|
$
|
(1.14
|
)
|
$
|
(3.52
|
)
|
$
|
(2.38
|
)
|
$
|
(22.99
|
)
|
$
|
4.12
|
|||||||||
|
Number of shares used in computing net diluted earnings (loss) per share (GAAP)
|
59,828,042
|
59,278,269
|
58,567,394
|
58,121,502
|
57,467,946
|
58,954,380
|
57,082,182
|
57,237,518
|
||||||||||||||||||||||||
|
Stock-based compensation
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
725,859
|
||||||||||||||||||||||||
|
Notes due 2025
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
2,276,818
|
||||||||||||||||||||||||
|
Number of shares used in computing net diluted earnings (loss) per share (Non-GAAP)
|
59,828,042
|
59,278,269
|
58,567,394
|
58,121,502
|
57,467,946
|
58,954,380
|
57,082,182
|
60,240,195
|
||||||||||||||||||||||||
|
Net cash provided by (used in) operating activities (GAAP)
|
$ |
52,629
|
$ |
25,608
|
$ |
(7,799
|
)
|
$ |
33,823
|
$ |
37,804
|
$ |
104,261
|
$ |
(313,319
|
)
|
$ |
(180,113
|
)
|
|||||||||||||
|
Purchases of property and equipment
|
(9,293
|
)
|
(2,809
|
)
|
(1,256
|
)
|
(10,109
|
)
|
(12,258
|
)
|
(23,467
|
)
|
(108,163
|
)
|
(170,523
|
)
|
||||||||||||||||
|
Discontinued operation
|
—
|
—
|
—
|
(3,867
|
)
|
—
|
(3,867
|
)
|
—
|
—
|
||||||||||||||||||||||
|
Free cash flow (deficit) (Non-GAAP)
|
$ |
43,336
|
$ |
22,799
|
$ |
(9,055
|
)
|
$ |
19,847
|
$ |
25,546
|
$ |
76,927
|
$ |
(421,482
|
)
|
$ |
(350,636
|
)
|
|||||||||||||